丁猛 博士
合夥人, 盛德律師事務所
Dr Meng Ding has extensive experience counselling issuers and investment banks on a broad spectrum of capital markets and M&A transactions. He focuses his practice on companies from Greater China and Asia companies, frequently advising on transactions that define their growth and success, from early-stage financing to listings to post-listing matters.
He has advised on a number of Hong Kong and U.S. IPOs, bond offerings, and many of Greater China’s largest, most complex, and precedent-setting transactions, including the first Chapter 18C Specialist Technology Company IPO (XtalPi, Inc.) and the first Chapter 18B De-SPAC listing. He has also advised many Chapter 18A biotech company IPOs. Meng is notable for his ground-up approach to gain deep understanding of industries, ranging from e-commerce platforms to specialist hard-tech companies such as semiconductor, AI, robotics, autonomous driving companies to life science and pharmaceutical firms to financial institutions.
[Last updated: April 2026 | Provided in English only]